Genitourinary Cancer
Commentary
Cancer Treatment 101: A Primer for Non-Oncologists
Doctor explains why he thinks time of diagnosis is the best time for molecular testing of a new malignant tumor.
From the Journals
Can Belzutifan Improve Outcomes in Advanced RCC?
Researchers compared the efficacy and safety of belzutifan with everolimus in patients with advanced clear cell renal cell carcinoma.
Feature
When Childhood Cancer Survivors Face Sexual Challenges
The disruptions caused by cancer and its treatment can interfere with normal physiological and psychological development, leading to issues with...
From the Journals
Few Severe Toxicities After SBRT in Oligometastatic Cancer
SBRT, an alternative to chemotherapy and immunotherapy, offers treatment with a low rate (0.5%) of severe acute toxicities.
Feature
BRCA Mutations in Men: Important but Often Overlooked
Most are unaware of the associated cancer risks, and management recommendations for male BRCA carriers.
Feature
Immunotherapy May Be Overused in Dying Patients With Cancer
“There are patients who are getting immunotherapy who shouldn’t,” according to a surgical oncologist from Yale.
From the Journals
Can Addressing Depression Reduce Chemo Toxicity in Older Adults?
Researchers evaluated whether greater reductions in grade 3 chemotherapy-related toxicities occurred with geriatric assessment-driven...
Latest News
Artera Launches AI Test for Decision-Making on Prostate Cancer Treatment Course
The test estimates how a patient’s cancer may progress and predicts the benefit of treatment for localized prostate.
News from the FDA/CDC
FDA Approves First Engineered Cell Therapy for a Solid Tumor
This T-cell receptor therapy modifies existing receptors to recognize an array of antigens on the surface of cancer cells.
From the Journals
The Last 30 Days: How Oncologists’ Choices Affect End-of-Life Cancer Care
Researchers analyze data from more than 17,000 patients who died of cancer between 2012 and 2017.
From the Journals
Ancient Viruses in Our DNA Hold Clues to Cancer Treatment
Targeting remnants of a virus in our DNA could lead to more effective cancer treatment with fewer side effects.